New lung cancer combo shows promise in early trial

NCT ID NCT06810609

Recruiting now Disease control Sponsor: University Hospital, Bonn Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving immunotherapy and chemotherapy before surgery or radiation, followed by more immunotherapy, can help people with stage III lung cancer live longer without the cancer coming back. About 176 adults with resectable or borderline resectable non-small cell lung cancer will take part. The goal is to see if this approach works better than current treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER NON-SMALL CELL CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER NON-SMALL CELL CANCER (NSCLC)

Contacts and locations

Locations

Johannes Wesling Klinikum Minden Mühlenkreiskliniken, Hämatologie und Onkologie
RECRUITING

Minden, North Rhine-Westphalia, 32429, Germany
Klinikum Stuttgart
RECRUITING

Stuttgart, Baden-Wurttemberg, 70174, Germany
University Hospital Bonn
RECRUITING

Bonn, 53127, Germany
University Hospital Freiburg
RECRUITING

Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
University Hospital Gießen
NOT_YET_RECRUITING

Giessen, Hesse, 35392, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.